Drug Trial Radar · NCT03902080
Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)
Last checked: Nov 20, 2026Latest source record: Aug 7, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,105
Actual
Start
Mar 26, 2019
Primary completion
Jun 15, 2023
Study completion Jun 15, 2023
Sponsor
- Lead sponsor
- Urovant Sciences GmbHIndustry
- Sponsor type
- Industry
- First posted
- Apr 3, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will assess the efficacy of vibegron compared with placebo in men with overactive bladder (OAB) symptoms on pharmacological therapy for benign prostatic hyperplasia (BPH) as defined by micturition and urgency episodes.
Conditions
- Overactive Bladder
Interventions
VibegronDrug
oral administration
PlaceboDrug
oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline at Week 12 in the Average Number of Micturition Episodes Per DayTime frame: Baseline; Week 12
- Change From Baseline at Week 12 in the Average Number of Urgency Episodes (Need to Urinate Immediately) Per DayTime frame: Baseline; Week 12
Locations
140 sites in 8 countries. Site status is shown where the registry gives one.
Urology Centers of Alabama
Homewood, Alabama
Private Practice
Huntsville, Alabama
Coastal Clinical Research, Inc.
Mobile, Alabama
Gen1 Research- Arizona Urology Specialists
Glendale, Arizona
Urological Associates Of Southern Arizona
Tucson, Arizona
California Research Medical Group, Inc.
Fullerton, California
San Diego Clinical Trials
La Mesa, California
Clinical Trials Research
Lincoln, California
West Coast Urology
Los Alamitos, California
American Institute of Research
Los Angeles, California
Norris Comprehensive Cancer Center
Los Angeles, California
Tri Valley Urology Medical Group
Murrieta, California
Northern California Research Corp
Sacramento, California
Medical Center for Clinical Research
San Diego, California
Urology Specialists of Southern California (USSC)
Sherman Oaks, California
Skyline Urology
Torrance, California
Urology Associates - Urology
Denver, Colorado
Imagine Research of Palm Beach County - Urology
Boynton Beach, Florida
Tampa Bay Medical Research
Clearwater, Florida
Urological Research Network Corp
Hialeah, Florida
LCC Medical Research Institute
Miami, Florida
Quantum Clinical Trials
Miami, Florida
Private Practice
Orlando, Florida
Urology Center Of Florida
Pompano Beach, Florida
Pinellas Urology, Inc.
St. Petersburg, Florida
Precision Clinical Research
Sunrise, Florida
Florida Urology Partners, LLP
Tampa, Florida
Clinical Research of Central Florida
Winter Haven, Florida
Meridian Clinical Research - Urology
Savannah, Georgia
Idaho Urologic Institute
Meridian, Idaho
NorthShore University Health System
Glenview, Illinois
First Urology
Jeffersonville, Indiana
The Iowa Clinic
West Des Moines, Iowa
GU Research Network/Wichita Urology Group
Wichita, Kansas
DelRicht Research
New Orleans, Louisiana
Regional Urology, LLC
Shreveport, Louisiana
Chesapeake Urology Research Associates
Baltimore, Maryland
Boston Clinical Trials Inc - Urology
Boston, Massachusetts
Mens Health Boston - Urology
Chestnut Hill, Massachusetts
Bay State Clinical Trials, Inc.
Watertown, Massachusetts
Showing 40 of 140 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.